KEGG DRUG

Search results

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	Disease ID
1	Risankizumab	[1] Risankizumab	[1] Risankizumab 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[4] 37, 96, 97, 271 💬
2	Risankizumab (Genetical Recombination)	[1] Risankizumab	[1] Risankizumab 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 97 💬
3	Risankizumab 10 mg/ml	[1] Risankizumab	[1] Risankizumab 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96 💬
4	Risankizumab 180 mg SC	[1] Risankizumab	[1] Risankizumab 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96 💬
5	Risankizumab 600 mg IV	[1] Risankizumab	[1] Risankizumab 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96 💬
6	Risankizumab 90 mg/ml	[1] Risankizumab	[1] Risankizumab 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96 💬
7	Risankizumab IV	[1] Risankizumab	[1] Risankizumab 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[2] 96, 97 💬
8	Risankizumab On-Body Injector (OBI)	[1] Risankizumab	[1] Risankizumab 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[1] 96 💬
9	Risankizumab SC	[1] Risankizumab	[1] Risankizumab 💬	[1] IL23A 💬	[9] C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬	[2] 96, 97 💬